#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia refractory Inborn error of metabolism Hereditary motor and sensory neuropathy Non-small cell lung cancer Autoinflammation with infantile enterocolitis Allogenic stem cell transplantation Intracranial calcification Myelofibrosis Factor IX deficiency Post transplant lymphoproliferative disorder Small cell lung cancer recurrent Arginase deficiency Oesophageal atresia Ovarian epithelial cancer Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Basic Information Alveolar rhabdomyosarcoma Adrenocortical carcinoma – Treatment Ewing’s sarcoma recurrent Richter’s syndrome – Diagnostics Myxofibrosarcoma – Life with Disease Rett syndrome – Diagnostics Erdheim-Chester disease Encephalitis autoimmune – Trials in Disease Prader-Willi syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BMS-986365 SODIUM DIHYDROGEN PHOSPHATE Trastuzumab Soya Oil, Purified Pelareorep Bilastine Bt8009 Aciclovir Sirexatamab Fluorometholone INDAPAMIDE HEMIHYDRATE Alpha1H Sacituzumab Govitecan Cefazolin Sodium Ttf-Ngr Cariprazine Hydrochloride Hmb-001 Tamsulosin Hydrochloride HUMAN COAGULATION FACTOR XIII Dexamethasone Base More therapies…

    Learn about Your Condition

    Skin cancer Cystic fibrosis Decreased appetite Gestational diabetes Liver disorder Anxiety disorder Syphilis Spinal osteoarthritis Agitation postoperative Testis cancer Limb reduction defect Pancreatic failure Ovarian cancer stage III Nocturia Systemic infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Ensifentrine for Patients with Non-Cystic Fibrosis Bronchiectasis

    Recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • ENSIFENTRINE
    Italy Spain

  • Study of alpha-1 antitrypsin given intravenously to hospitalized patients during COPD exacerbation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    • Sodium Chloride
    Italy

  • Study on Dupilumab and Fexofenadine for Treating Indolent Systemic Mastocytosis with Skin Involvement in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic mastocytosis
    Investigated Drugs:
    • Fexofenadine Hydrochloride
    • Dupilumab
    • Sodium Chloride
    Poland

  • Study of Danicopan with Ravulizumab or Eculizumab for Children with Paroxysmal Nocturnal Hemoglobinuria and Extravascular Hemolysis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Danicopan
    France Germany

  • Study on the Effectiveness and Safety of AZD0486 for Adults with Relapsed or Refractory Non-Hodgkin Lymphoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Follicular lymphoma
    • Diffuse large B-cell lymphoma recurrent
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
    Denmark France Germany Italy Spain Sweden

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Investigated Drugs:
    • Amikacin
    • Benzylpenicillin Sodium
    • Cefuroxime Sodium
    Denmark
Previous Page
1 … 285 286 287 288 289 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!